SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (115)2/7/2001 4:40:21 PM
From: scaram(o)uche  Read Replies (1) of 1022
 
Yeah. I guess that the focus has rapidly and AGGRESSIVELY turned to minimization of mfg. costs, up front.

Makes sense..... for most applications, one is going to want extremely high affinity MAbs. In some situations, you'll only be able to get composition of matter, and that doesn't do much in the realm of antibodies.

>> "low double digit" <<

My, oh, my.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News